Literature DB >> 12360143

Nosocomial infections among HIV-positive and HIV-negative patients in a Brazilian infectious diseases unit.

Maria Clara Padoveze1, Plínio Trabasso, Maria Luiza Moretti Branchini.   

Abstract

BACKGROUND: Some researchers observed that HIV-infected patients have a higher risk of acquiring nosocomial infections (NI). This study compared the incidence of NI among HIV-positive and HIV-negative inpatients.
METHODS: Patients from an infectious diseases ward who were classified as positive and negative regarding their HIV status were followed-up for 21 months in a prospective cohort study. Daily surveillance was made with use of Centers for Disease Prevention and Control criteria for NI.
RESULTS: NI per 1000 patients-day were 8.16 for HIV-positive patients and 3.94 for HIV-negative patients (P =.01). Central venous catheter (CVC) and urinary catheter utilization was significantly higher among HIV-positive patients than among HIV-negative patients (P <.001). Bloodstream infections (BSI) caused most of the NI, followed by urinary tract infections, vascular infections, and pneumonia. Overall, HIV-positive patients were more likely to have a BSI than were HIV-negative patients (P =.005). When only BSI was analyzed in patients with a CVC, there was no difference in the incidence of BSI between the 2 groups of patients (P =.24). HIV-positive patients were more likely to have an NI caused by Staphylococcus aureus than were HIV-negative patients (P =.04). Other important NI agents in both groups were Acinetobacter baumanii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and coagulase-negative Staphylococcus.
CONCLUSIONS: In this study the HIV-positive patients were more likely to have NI than were the HIV-negative patients. Overall, HIV-positive patients are at increased risk for an NI caused either by S aureus or a BSI. Although HIV-positive patients had more CVC-days, there was no difference in the number of BSI among both groups, suggesting that the BSI incidence in the HIV-positive group is not exclusively related to the CVC.

Entities:  

Mesh:

Year:  2002        PMID: 12360143     DOI: 10.1067/mic.2002.125220

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  9 in total

1.  Clinico-microbiological study of Pseudomonas aeruginosa in wound infections and the detection of metallo-β-lactamase production.

Authors:  Divya Bangera; Suchitra M Shenoy; Dominic Rm Saldanha
Journal:  Int Wound J       Date:  2015-10-30       Impact factor: 3.315

2.  Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy.

Authors:  Jared A Greenberg; Jeffrey L Lennox; Greg S Martin
Journal:  J Crit Care       Date:  2011-10-26       Impact factor: 3.425

3.  Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.

Authors:  Simone Aranha Nouér; Marcio Nucci; Márcia P de-Oliveira; Flávia Lúcia Piffano Costa Pellegrino; Beatriz Meurer Moreira
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

4.  Risk of healthcare associated infections in HIV positive patients.

Authors:  Mohammed Mitha; E Yoko Furuya; Elaine Larson
Journal:  J Infect Prev       Date:  2014-11-01

Review 5.  Urologic complications of HIV and AIDS.

Authors:  Chris F Heyns; Adam E Groeneveld; Nelson B Sigarroa
Journal:  Nat Clin Pract Urol       Date:  2009-01

6.  Methicillin-resistant Staphylococcus aureus in HIV-infected patients.

Authors:  Alicia I Hidron; Russell Kempker; Abeer Moanna; David Rimland
Journal:  Infect Drug Resist       Date:  2010-08-06       Impact factor: 4.003

7.  Impact of human immunodeficiency virus infection on mortality of patients who acquired healthcare associated-infection in critical care unit.

Authors:  Victor Augusto Camarinha de Castro-Lima; Igor C Borges; Daniel Joelsons; Vivian V T Sales; Thais Guimaraes; Yeh Li Ho; Silvia F Costa; Maria Luisa N Moura
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

8.  Immuno-virological status and its associated factors among HIV-positive patients receiving highly active antiretroviral therapy at delgi primary hospital, northwest Ethiopia, 2020/2021: A cross-sectional study.

Authors:  Teklehaimanot Kiros; Abebe Taye; Lemma Workineh; Tahir Eyayu; Shewaneh Damtie; Wasihun Hailemichael; Tegenaw Tiruneh
Journal:  Heliyon       Date:  2022-08-09

9.  Nosocomial infections in human immunodeficiency virus type 1 (HIV-1) infected and AIDS patients: major microorganisms and immunological profile.

Authors:  C Panis; T Matsuo; E M V Reiche
Journal:  Braz J Microbiol       Date:  2009-03-01       Impact factor: 2.476

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.